Monday, February 25, 2019

Higher Dose Of Xeljanz Tied To Blood Clots In Lungs, Death In RA Patients

There is an increased risk of blood clots in the lungs and death when a 10 mg twice daily dose of Pfizer Inc's (PFE) Xeljanz or Xeljanz XR is used in patients with rheumatoid arthritis, warns the FDA.

from RTT - Biotech https://ift.tt/2BQEmbq
via IFTTT

No comments:

Post a Comment